Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 14/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.34 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.34 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.34 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL139102 | 0.88 | ACHE (0.48) | ACHEEPHX1HDAC3HDAC4HDAC1 | |
| SCHEMBL809069 | 0.86 | ACHE (0.61) | ACHE | |
| SCHEMBL27030671 | 0.85 | ACHE (0.46) | ACHEEPHX1HDAC3HDAC4HDAC1 | |
| Ammonia Solution, Strong SCHEMBL9998894 | 0.83 | ACHE (0.54) | ACHE | |
| SCHEMBL20544859 | 0.83 | ACHE (0.44) | ACHEEPHX1HDAC3HDAC4HDAC1 | |
| SCHEMBL16160556 | 0.83 | ACHE (0.58) | ACHEEPHX1 | |
| SCHEMBL300412 | 0.83 | ACHE (0.47) | ACHEEPHX1HDAC3HDAC4HDAC1 | |
| SCHEMBL3401549 | 0.82 | EPHX1 (0.55) | ACHEEPHX1 | |
| SCHEMBL18198077 | 0.82 | ACHE (0.65) | ACHE | |
| SCHEMBL9389713 | 0.82 | ACHE (0.62) | ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9926339-B2 | Fluorine-containing silane compound | MITSUBISHI MATERIALS CORPORATION (JP) | 2018-03-27 | — | — | US | disclosed |
| US-20170145039-A1 | FLUORINE-CONTAINING SILANE COMPOUND | MITSUBISHI MATERIALS CORPORATION (JP) | 2017-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170145039-A1 | FLUORINE-CONTAINING SILANE COMPOUND | PFAS, AFF1, AFF2 | ACHE 2900/4885EPHX1 1967/4885HDAC3 2671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.